Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.
Department of Oral and Maxillofacial Surgery, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan.
Int J Mol Sci. 2020 May 22;21(10):3655. doi: 10.3390/ijms21103655.
Because oral squamous cell carcinomas (OSCCs) have a high potential for locoregional invasion and nodal metastasis, early detection and treatment are essential. A LAP2, emerin, MAN1 (LEM) domain containing 1 (LEMD1) is associated with local progression, clinical stage, nodal metastasis, poor prognosis, angiogenesis, and lymphangiogenesis in OSCC. Although LEMD is a cancer-testis antigen, the cancer-related signals related to LEMD1 remain unknown. In this study, we used a microarray analysis of OSCC cells to identify sushi repeat containing protein X-linked 2 () as a -related downstream signal. LEMD1 expression was correlated with lymph node metastasis of OSCC according to the immunohistochemistry analysis. Furthermore, patients expressing SRPX2 had a significantly worse prognosis than those without SRPX2 expression. The concentration of SRPX2 in OSCC was positively correlated with the concentrations of LEMD1, urokinase plasminogen activator receptor (uPAR), and hepatocyte growth factor (HGF). In OSCC cells, SRPX2 secretion levels were elevated by interactions with uPAR and HGF. We also found that SRPX2 promotes endothelial cell proliferation and adhesion between endothelial cells and OSCC cells. These results suggest that SRPX2 might be a useful tumor marker for OSCC.
由于口腔鳞状细胞癌(OSCC)具有局部侵袭和淋巴结转移的高潜力,因此早期检测和治疗至关重要。一个含有 LAP2、emerin、MAN1(LEM)结构域的 1 型(LEMD1)与 OSCC 的局部进展、临床分期、淋巴结转移、不良预后、血管生成和淋巴管生成有关。尽管 LEM 是一种癌睾丸抗原,但与 LEMD1 相关的癌症相关信号仍不清楚。在这项研究中,我们使用 OSCC 细胞的微阵列分析来鉴定出 sushi repeat containing protein X-linked 2 () 作为与相关的下游信号。根据免疫组织化学分析,LEMD1 的表达与 OSCC 的淋巴结转移相关。此外,表达 SRPX2 的患者的预后明显比不表达 SRPX2 的患者差。OSCC 中 SRPX2 的浓度与 LEMD1、尿激酶纤溶酶原激活物受体(uPAR)和肝细胞生长因子(HGF)的浓度呈正相关。在 OSCC 细胞中,SRPX2 的分泌水平通过与 uPAR 和 HGF 的相互作用而升高。我们还发现,SRPX2 可促进内皮细胞增殖以及内皮细胞与 OSCC 细胞之间的黏附。这些结果表明,SRPX2 可能是 OSCC 的一种有用的肿瘤标志物。